Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020

Serological reactivity was analysed in plasma from 436 individuals with a history of disease compatible with COVID-19, including 256 who had been laboratory-confirmed with SARS-CoV-2 infection. Over 99% of laboratory-confirmed cases developed a measurable antibody response (254/256) and 88% harboure...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Euro Surveill
Prif Awduron: Harvala, Heli, Mehew, Jennifer, Robb, Matthew L, Ijaz, Samreen, Dicks, Steven, Patel, Monika, Watkins, Nicholas, Simmonds, Peter, Brooks, Tim, Johnson, Rachel, Gopal, Robin, Roberts, David J, Zambon, Maria, Thomas, Stephen, MacLennan, Sheila, Estcourt, Lise, Brailsford, Su, Baklan, Hatice, Tettmar, Kate, Kellington, Jeremy, Sell, Joanne, Miflin, Gail
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: European Centre for Disease Prevention and Control (ECDC) 2020
Pynciau:
Rapid Communication
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7376844/
https://ncbi.nlm.nih.gov/pubmed/32700670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2001260
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg